Goodwill of Neuphoria Therapeutics Inc. from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary: Neuphoria Therapeutics Inc. quarterly Goodwill in USD history and change rate from 30 Jun 2022 to 31 Dec 2025.
Neuphoria Therapeutics Inc. Goodwill for the quarter ending 31 Dec 2025 was $8,737,953, a 3.9% increase year-over-year.
Source SEC data: View on sec.gov

Goodwill, Quarterly (USD)

Goodwill, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Goodwill (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$8,737,953	+$330,682	+3.9%	31 Dec 2025	10-Q	17 Feb 2026	2025	Q2
Q3 2025	$8,674,734	-$229,254	-2.6%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q1
Q2 2025	$8,638,609	-$51,409	-0.59%	30 Jun 2025	10-Q	17 Feb 2026	2025	Q2
Q1 2025	$8,451,038	-$175,066	-2%	31 Mar 2025	10-Q	20 May 2025	2025	Q3
Q4 2024	$8,407,271	-$432,804	-4.9%	31 Dec 2024	10-Q	17 Feb 2026	2025	Q2
Q3 2024	$8,903,988	+$329,292	+3.8%	30 Sep 2024	10-Q	14 Nov 2025	2025	Q1
Q2 2024	$8,690,018	-$4,168	-0.05%	30 Jun 2024	10-Q	17 Feb 2026	2025	Q2
Q1 2024	$8,626,104			31 Mar 2024	10-Q	20 May 2025	2025	Q3
Q4 2023	$8,840,075			31 Dec 2023	10-Q	14 Feb 2025	2025	Q2
Q3 2023	$8,574,696			30 Sep 2023	10-Q	14 Nov 2024	2025	Q1
Q2 2023	$8,694,186	-$179,930	-2%	30 Jun 2023	10-K	29 Sep 2025	2025	FY
Q2 2022	$8,874,116			30 Jun 2022	10-K	30 Sep 2024	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.